The Office of Patented Medicines and Liaison (OPML) within Health Canada released proposed revisions to its PM(NOC) Guidance Document relating to administrative new drug submissions and administrative abbreviated new drug submissions.
The Federal Court of Appeal upheld the trial decision of Justice Gauthier in the decision Phostech v. Valence2011 FCA 237 (PDF) finding that the trial judge made no error in construing the claim to find the patent valid and infringed.
Last week, in Tucows.Com Co. v. Lojas Renner, 2011 ONCA 548, the Ontario Court of Appeal determined that a domain name was “personal property in Ontario” for the purposes of jurisdiction under Rule 17.02(a) after a UDRP proceeding had already been started.
Earlier today, the U.S. Court of Appeals for the Federal Circuit in Myriad Genetics held that isolated genes are patent-eligible subject matter, reversing the lower court in part (PDF).
Earlier today, UK’s highest court held in Lucasfilm Ltd v Ainsworth that the English courts can decide the issue of infringement of U.S. copyright where there is jurisdiction over the defendant. Continue reading UK Supreme Court on enforcement of foreign IP→
CIRA has announced that they are implementing a new set of policies and rules for domain name disputes. The new CDRP includes changes to the meaning of “use”, “confusingly similar” and “bad faith” along with a host of other changes and will come into force August 22, 2011.
In decision released yesterday, the Federal Court of Appeal considered the application of s.73(1)(a) ‘good faith’ under the Patent Act and held that “Its operation is extinguished once the patent issues.” (PDF of decision) Dimock Stratton represented two of the respondents in the case and has a summary available.
I was away last week on vacation and unfortunately my computer failed while I was away. It is up and running now and today’s email should include all the updates for the past week. Sorry for the interruption!
Canadian Intellectual Property
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkNo